^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Ewing Sarcoma
    Drug:Stivarga (regorafenib) (Multi-tyrosine kinase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    08/07/2023
    Excerpt:
    Bone Cancer: Ewing Sarcoma…Other Recommended Regimens...Regorafenib...